CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- 144 Insider Sale of Securities
- 4 Open-market sale PRESIDENT, CLINICALDIAGNOSTICS sold 4,692 shares at $230.76 ($1,082,714)
- 4 Open-market sale Director sold 48,419 shares at an average $227.42 ($11,011,477)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Option exercise Director acquired 4,436 shares (option exercise)
- S-3ASR Offering Registration Statement
- RW Other RW
- 4 Open-market sale Director sold 4,366 shares at an average $243.10 ($1,061,389)
- 4 Option exercise SEC. AND CHIEF LEGAL OFFICER acquired 6,902 shares (option exercise)
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-3 Offering Registration Statement
- 8-K Event Unregistered share sale · Other events
- 4 Planned sale PRESIDENT, CLINICALDIAGNOSTICS sold 3,000 shares at an average $238.15 ($714,459)
- 4 Planned sale CEO AND PRESIDENT sold 4,400 shares at an average $238.07 ($1,047,502)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 75,000 shares at an average $236.12 ($17,708,936)
- 144 Insider Sale of Securities
Page 15 of 94 · 1,862 filings